Status:
TERMINATED
An Investigational Drug Study In Patients With COPD (Chronic Obstructive Pulmonary Disease) (MK-0873-005)
Lead Sponsor:
Merck Sharp & Dohme LLC
Conditions:
Lung Diseases
Pulmonary Disease, Chronic Obstructive
Eligibility:
All Genders
40-75 years
Phase:
PHASE2
Brief Summary
This is a study to evaluate the effectiveness and tolerability of a once-daily oral medication (MK-0873) for the treatment of COPD (chronic obstructive pulmonary disease) to determine whether the stud...
Detailed Description
Following a three-week run-in period (Period I) during which participants received placebo, participants entered into a 12-week double-blind treatment period (Period II) during which they received dai...
Eligibility Criteria
Inclusion
- Males and females, 40 to 75 years old, with a history consistent with COPD (chronic obstructive pulmonary disease)
- Lung function tests that meet the requirements of the study
Exclusion
- Severe and unstable medical conditions other than COPD (chronic obstructive pulmonary disease)
- Use of continuous oxygen therapy
- Cardiac (heart) arrhythmias
- Other lung disease
- History of colitis (inflammation of the colon)
Key Trial Info
Start Date :
June 1 2004
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 17 2005
Estimated Enrollment :
604 Patients enrolled
Trial Details
Trial ID
NCT00132730
Start Date
June 1 2004
End Date
August 17 2005
Last Update
October 12 2018
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.